SAS Contract Jobs in London

The SAS contractor role centres on the ability to develop, maintain, and optimise analytical programmes and data management workflows using the SAS statistical software platform, which remains the dominant analytical platform across the pharmaceutical, financial services, healthcare, and insurance sectors in the UK. SAS's strength in regulated industry analytics, clinical trial data management and statistical programming for CDISC submission, credit risk modelling, and insurance actuarial analysis has created a stable and specialist contracting market driven by the large installed base of SAS in these industries. Contract engagements involve developing SAS programs for data manipulation, statistical analysis, reporting, and automated processing, migrating legacy SAS code to newer SAS versions or to alternative platforms, and providing specialist SAS programming expertise for specific analytical projects.

SAS contractors are expected to have strong proficiency in Base SAS programming, including DATA step processing, PROC SQL, macro programming, and SAS formats and informats. For pharmaceutical statistical programming roles, familiarity with SAS for clinical trials, including the CDISC SDTM and ADaM standards for clinical data formatting, and experience producing TLFs (tables, listings, and figures) for regulatory submission packages, is expected. For financial services and credit risk roles, experience using SAS Enterprise Guide or SAS Studio for credit scoring model development, SAS Risk Management frameworks, or the SAS Visual Analytics platform for BI and reporting is the relevant technical requirement. For regulatory submissions, knowledge of PROC REPORT, Output Delivery System, and the specific SAS procedures used in clinical and actuarial analysis is expected alongside the data management and statistical programming competencies.

SAS contracting is a specialist and stable market defined by the characteristics of the industries where SAS maintains its strongest foothold. Pharmaceutical statistical programming for clinical trial submissions to FDA, EMA, and MHRA is the highest-value and most consistently active segment of the SAS contractor market, as the regulatory requirement to submit clinical data in SAS-formatted CDISC datasets creates structural demand for SAS programmers with CDISC expertise. Financial services credit risk analytics and insurance actuarial analysis are the other primary sources of SAS contract demand. The market is not growing in the way that Python and R-based analytics contracting is, but the regulatory requirements and large installed base in pharmaceutical and financial services create resilient ongoing demand. Rates for experienced pharmaceutical SAS programmers with CDISC submission experience are at the premium end of the analytical programming contractor market.

London dominates the UK contractor market by volume, depth, and rate levels. The capital concentrates the headquarters and major offices of most FTSE 100 companies, the largest global banks, the Big Four professional services firms, and the central government departments that collectively generate the majority of UK contract demand. Every contracting discipline covered on this site has active demand in London, from niche specialisms like threat intelligence and LLM engineering through to high-volume disciplines like project management and business analysis. The sheer density of employers means contractors in London typically have more choice of engagement at any given time than anywhere else in the UK. Day rates carry a premium of 15 to 25 per cent over the national average across most disciplines, reflecting both the concentration of complex, high-value programmes and the cost of operating in the capital.

Contract rates for sas roles in London typically range from £495 to £880 per day, depending on the scope of the role, required expertise, and the delivery expectations of the engagement.

Over the past twelve months, we have tracked over 100 sas contract roles across the site, with London accounting for roughly one in three of those. Data reviewed up to March 2026.